Juan F. Iglesias

Juan F. Iglesias

Interventional cardiologist / Cardiologist
Geneva University Hospitals - Geneva, Switzerland

Latest contributions

“BIO-PCI” the turning point of vascular interventions?

03 Dec 2024

Discuss the rationale of a PCI strategy with minimal metal as a turning point of vascular interventions with Flavio Luciano Ribichini, Salvatore Brugaletta and Piera Capranzano.

CathWorks FFRangio - Enhancing patient care

16 May 2024 – From EuroPCR 2024

Explore this EuroPCR 2024 session to gain an in-depth understanding of how FFRangio utilizes routine angiograms to provide valuable insights, delve into the integration of FFRangio-guided decisions for optimizing patient care, and examine the practical application of FFRangio in routine clinical practice, encompassing its benefits and challenges.

CathWorks FFRangio - Enhancing patient care

Revisiting thrombus aspiration in STEMI with continuous power aspiration system

15 May 2024 – From EuroPCR 2024

Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...

Revisiting thrombus aspiration in STEMI with continuous power aspiration system

PCI in patients with diabetes: next generation DES + DCB stent platform in action

14 May 2024 – From EuroPCR 2024

Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...

PCI in patients with diabetes: next generation DES + DCB stent platform in action

Bifurcation PCI

17 May 2023 – From EuroPCR 2023

View these cases that revolve around bifurcation PCI and enhance your skills in managing challenging situations. Topics covered include in particular complicated bifurcation stenting as well as hybrid culotte complex strategy. Explore these cases and much more and uncover numerous other valuable insights!

Bifurcation PCI

The next generation DES technology: innovative DES+DCB stent platform

Next generation of DES technology, what it's all about? Find out in this session where experts will present complex cases from around the world and discuss the new indications for which they can be used.

The next generation DES technology: innovative DES+DCB stent platform

Nightmares during primary PCI: large thrombus burden management in an ectatic Left anterior Descending Coronary Artery

08 Dec 2022

A 61-year-old man was admitted to the catheterization laboratory for anterior STEMI. Coronary angiography revealed a large thrombus burden in an ectatic and occluded LAD. How would you treat this challenging case? 

Dario Bongiovanni

Author

Dario Bongiovanni
Antonio Landi

Author

Antonio Landi

Author

Francesco Loizzi
Marco Valgimigli

Author

Marco Valgimigli

What's next in DES technology? Innovative DES platforms combining DES with DCB

19 May 2022 – From EUROPCR 2022

Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...

What's next in DES technology? Innovative DES platforms combining DES with DCB

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

PCR e-Course Hot lines: drugs and devices for STEMI management

Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.

Hot line: drugs and devices for STEMI management

Ultrathin-strut vs. thin-strut DES for primary PCI

27 Jun 2020 – From PCR e-Course 2020

Watch this session to review the role of ultrathin DES in optimising clinical outcomes for STEMI patients, to assess the impact of the BIOSTEMI trial to daily practice and to learn about real-world challenges when treating STEMI patients.

Videos included on this page: the Hot Line presentation...

Ultrathin-strut vs. thin-strut DES for primary PCI

Contemporary strategies for challenging diseases: optimising treatments with ultrathin strut DES

22 May 2019 – From EuroPCR 2019

Consult this session on ultrathin strut drug-eluting stent to learn more about its role in treating complex lesions and patient types, and to discover contemporary approaches to manage various challenging cases, such as ACS STEMI, CTO, and more!

Contemporary strategies for challenging diseases: optimising treatments with ultrathin strut DES

Latest generation DES - What do I need to know?

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about the latest generation drug-eluting stents, such as the dynamX novolimus-eluting bioadaptor, and discover the results of various clinical trials: ANGIOLITE, DIRECT II, and more! 

Latest generation DES - What do I need to know?